Meso Aftermath Archived

Renouveau du biotech : activité de M&A et performance du marché

Activité en déclin — le récit perd de sa pertinence.

Score
0,3
Vélocité
▲ 0,0
Articles
13
Sources
2

Plus fortes variations

TickerSecteurVariation
VRA
Consumer Discretionary+17,4%
VRTX
Healthcare+16,3%

Chronologie des sentiments

Performance Sectorielle

Performance des actions

Chronologie des événements

Mar 31, 2026
MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance Neutral
Mar 26, 2026
2 Healthcare Stocks That Could Soar Over the Next 5 Years Bullish
Mar 25, 2026
Moderna Stock is Soaring. Is It Too Late to Buy? Bullish
Mar 22, 2026
Two Biotech Stocks Hover Near Highs; Natural Gas And Finance Names Show … Bullish
Mar 21, 2026
This Biotech Was Quietly Bought Before a $58 Per Share Takeout Bullish
Mar 20, 2026
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA … Bullish

Articles Liés

This Biotech Was Quietly Bought Before a $58 Per Share Takeout

Yahoo Finance · Mar 21, 2026
Mixed

This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year

Nasdaq · Mar 20, 2026
Mixed

My Top 3 Drug Stocks for March 2026

Nasdaq · Mar 20, 2026
Bearish

Why biotech is back: IBT portfolio manager’s view

Yahoo Finance · Mar 20, 2026
Mixed

Chronologie

Première observationMar 20, 2026
Dernière mise à jourMar 20, 2026